-
BREAST CANCER RES TR: Asian data released!
Time of Update: 2021-10-10
Myocardial infarctionIn summary, the results of the subgroup analysis of the study showed that the efficacy characteristics of Asian patients with HER2-positive advanced breast cancer who had failed two or more HER2-targeted therapies were consistent with the efficacy characteristics of the entire study population, neratinib + capecita Bin can benefit them significantly, and no new safety issues have been seen .
-
Consensus guidelines on nutritional therapy for patients with biliary tumors
Time of Update: 2021-10-10
A number of randomized case-control studies or retrospective analysis showed that patients with malignant obstructive jaundice who underwent PTCD, received bile reinfusion combined with enteral nutrition significantly improved gastrointestinal function compared with those who did not undergo bile reinfusion, including reduction of diarrhea and gastric emptying Reduced incidence of delay, increased tolerance of enteral nutrition, etc.
-
CSCO Conference Express Delivery of NSCLC Novel Immune Checkpoint Inhibitors Research Progress
Time of Update: 2021-10-10
At present, LAG3 monoclonal antibody is used as a single agent or combined with other therapies for the treatment of a variety of solid tumors.
At present, LAG3 monoclonal antibody is used as a single agent or combined with other therapies for the treatment of a variety of solid tumors.
-
Pancreas Lift and Pancreatic Movement CSCO Pancreatic Cancer Special Conference Express, one article to check the new progress of drug treatment!
Time of Update: 2021-10-10
A phase III clinical trial NAPOLI-1 study explored irinotecan liposomes combined with 5-fluorouracil + folinic acid The safety and effectiveness of the treatment of patients with metastatic pancreatic cancer after failure of previous gemcitabine-based chemotherapy regimens have reached the study endpoints in the total population (mOS 6.
-
J Clin Oncol: The efficacy of abiraterone acetate in patients with castration resistance and androgen receptor expression salivary gland cancer (SGC)
Time of Update: 2021-10-10
Studies have shown that abiraterone combined with luteinizing hormone releasing hormone agonist is an effective and safe second-line treatment for patients with castration resistance and androgen receptor expression salivary gland cancer (SGC) .
-
Breast Cancer Res: How to predict the risk of coronary heart disease in breast cancer survivors?
Time of Update: 2021-10-10
The ability of PRS to stratify the risk of coronary heart disease in breast cancer survivors: The cumulative incidence of women in the lowest one-fifth of the risk reached 5% at the age of 15.
-
Trends in cancer 14+ new discoveries in melanoma metabolome
Time of Update: 2021-10-10
In addition, compared with non-metastatic UM tumors, metastatic UM tumors show up-regulation of the expression of these genes, highlighting the potential link between increased mitochondrial metabolism and metastasis .
-
A new breakthrough in the treatment of allogeneic γδ T cells, the potential for tumor treatment appears
Time of Update: 2021-10-10
Introduction: The effect of allogeneic γδT cell treatment allows us to see a new hope for conquering cancerOn September 27th, at the introduction of allogeneic γδ-T cell immunotherapy and patient meeting held by Ji Dekang, the chief scientist of Ji Dekangmin, Professor Yin Zhinan, Dean of the Institute of Biomedical Translational Research of Jinan University, focused on the introduction of his research team.
-
Front Oncol: Fruquintinib + PD-1 inhibitor vs. Regorafenib + PD-1 inhibitor in the treatment of patients with refractory microsatellite stable metastatic colorectal cancer
Time of Update: 2021-10-10
In a phase II clinical study, the objective response rate (ORR) of regorafenib combined with nivolumab in the treatment of refractory mCRC (MSS or pMMR) was 36%, and the median progression-free survival (PFS) was 7.
-
Nat Nanotech: A major breakthrough in tumor immunotherapy, Li Yaping of Shanghai Institute of Medicine developed epigenetic regulation nanovesicles to improve tumor immunotherapy
Time of Update: 2021-10-10
The study improved tumor immunotherapy by engineering T lymphocyte membrane modified interferon epigenetic nanoinducers, and creatively constructed a "precise delivery + intelligent drug release integration" bionic nanovesicles, revealing the nano drug delivery The mechanism of action of the system has achieved a major breakthrough in inducing tumor-specific interferon and simultaneously overcoming immune tolerance .
-
Oncogene: Only melatonin helps sleep?
Time of Update: 2021-10-10
This study aims to clarify the potential effects of melatonin monotherapy and neratinib in the treatment of HER2+ breast cancer cell lines .
This study aims to clarify the potential effects of melatonin monotherapy and neratinib in the treatment of HER2+ breast cancer cell lines .
-
Eur J Anaesthesiol: Intraoperative lung ventilation protective strategy reduces postoperative complications after laparoscopic colorectal cancer resection: a randomized controlled trial
Time of Update: 2021-10-10
PurposePurpose purposeIt aims to determine whether the open lung strategy of moderate PEEP (6-8cmH2O) and repetitive LRMs can prevent postoperative complications in high-risk patients undergoing laparoscopic colorectal cancer resection under low tidal volume .
-
Pancreatic movement focuses on the latest developments in the field of pancreatic cancer, Professor Bai Li's in-depth comments
Time of Update: 2021-10-10
Despite the current research results It shows that non-coding RNA represented by tsRNA has a brighter application prospect in the diagnosis of pancreatic cancer, but it is still a long way from being widely used in clinical practice .
-
BMJ: Studies of over 100,000 people have proved that long-term intake of sugary drinks increases the risk of a variety of cancers, and breast cancer is as high as 22%!
Time of Update: 2021-10-10
A study published in Gut in 2021 showed that consuming more than two sugar-sweetened beverages a day will increase the risk of early-onset colon cancer in women by 118% .
-
Cell blockbuster: discovering new targets for cancer vaccines
Time of Update: 2021-10-10
On September 16, 2021, the MIT research team published a research paper titled: Antigen dominance hierarchies shape TCF1+ progenitor CD8 T cell phenotypes in tumors in the top international academic journal Cell .
-
Front Oncol: Comparison of the direct efficacy of bevacizumab or pembrolizumab combined with pemetrexed + platinum-based chemotherapy in the first-line treatment of driver-gene-negative advanced non-squamous non-small cell lung cancer (NSCLC)
Time of Update: 2021-10-10
Bevacizumab or pembrolizumab combined with pemetrexed + platinum-based chemotherapy are recommended as first-line treatment for patients with advanced non-squamous non-small cell lung cancer ( NSCLC ) with negative driver genes .
-
Eur J Cancer: Real clinical practice data of anti-PD-1 adjuvant treatment of melanoma!
Time of Update: 2021-10-10
Diagnosis and treatmentThis study aims to analyze the treatment mode, recurrence rate and adverse event rate of melanoma patients who actually receive adjuvant therapy in clinical practice through the patient data registered on the DMTR .
-
To combat complexity in an all-round way!
Time of Update: 2021-10-10
First review a knowledge point: systemic mastocytosis is divided into indolence (ISM), smoking type (SSM), aggressive (ASM), and associated hematological tumors (SM- AHN) and mast cell leukemia (MCL) five subtypes, of which the latter three are included in the advanced stage (AdvSM) category .
-
Prof. Zhiyan Liu: Interpretation of the updated pathological diagnosis of the 2021 edition of "CSCO Guidelines for Diagnosis and Treatment of Differentiated Thyroid Cancer", and explore the path to precision diagnosis and treatment of thyroid cancer
Time of Update: 2021-10-10
Therefore, in the "Chinese Standards for Diagnosis and Treatment of Thyroid Cancer (2018 Edition)", thyroid cancer molecular marker detection (such as BRAF V600E mutation, RAS mutation, RET/PTC rearrangement, etc.
-
Front Oncol: The best type of surgery and adjuvant treatment for stage T1N0M0 lung large cell neuroendocrine carcinoma
Time of Update: 2021-10-10
Like lobectomy, regional lymph node dissection can also improve the survival rate of patients with tumors smaller than 2 cm.
Like lobectomy, regional lymph node dissection can also improve the survival rate of patients with tumors smaller than 2 cm.
